Epidermal Growth Factor Receptor | | Target | Target | beta-Cellulin | | | | | | |
Glomerulonephritis | | Disease | Drug | Avonex (Interferon beta-1a)- FDA | | | | | | |
ERK1 | | Target | Target | beta-Cellulin | | | | | | |
Glucocorticoid Receptor | | Target | Target | Vitamin D Receptor Interacting Protein | | | | | | |
Hypocalcemia | | Disease | Target | Vitamin D Receptor Interacting Protein | | | | | | |
Erbb2 | | Target | Target | beta-Cellulin | | | | | | |
Relapsing Remitting Multiple Sclerosis | | Disease | Drug | Avonex (Interferon beta-1a)- FDA | | | | | | |
Endostatin | | Target | Target | Angiostatin K1-3 | | | | | | |
ERBB3 | | Target | Target | beta-Cellulin | | | | | | |
ERBB4 | | Target | Target | beta-Cellulin | | | | | | |
Epiregulin | | Target | Target | beta-Cellulin | | | | | | |
Alemtuzumab (Campath)- FDA | | Drug | Drug | Avonex (Interferon beta-1a)- FDA | | | | | | |
Azathioprine (Imuran)- FDA | | Drug | Drug | Avonex (Interferon beta-1a)- FDA | | | | | | |
Epigen | | Target | Target | beta-Cellulin | | | | | | |
Fracture | | Disease | Drug | Arixtra (Fondaparinux Sodium)- FDA | | | | | | |
Thrombocytopenia | | Disease | Drug | Arixtra (Fondaparinux Sodium)- FDA | | | | | | |
Colon Cancer | | Disease | Disease | Pancreatitis Chronic | | | | | | |
Thromboembolism | | Disease | Drug | Arixtra (Fondaparinux Sodium)- FDA | | | | | | |
Chronic Pain | | Disease | Disease | Pancreatitis Chronic | | | | | | |
Deep Vein Thrombosis | | Disease | Drug | Arixtra (Fondaparinux Sodium)- FDA | | | | | | |
Cancer | | Disease | Target | Glutathione S-Transferase A3 | | | | | | |
Cancer | | Disease | Target | Beta-Adrenergic Receptor Kinase 2 | | | | | | |
Carcinoma | | Disease | Target | Glutathione S-Transferase A3 | | | | | | |
Diabetes | | Disease | Disease | Neuropathy Diabetic | | | | | | |
Lung Cancer | | Disease | Target | Complement Component C3c | | | | | | |
Schizophrenia | | Disease | Target | Beta-Adrenergic Receptor Kinase 2 | | | | | | |
Prostate Cancer | | Disease | Target | Beta-Adrenergic Receptor Kinase 2 | | | | | | |
Hearing Loss | | Disease | Target | Glutathione S-Transferase A3 | | | | | | |
Antithrombin | | Target | Target | Beta-Adrenergic Receptor Kinase 2 | | | | | | |
Glyceraldehyde 3-Phosphate Dehydrogenase | | Target | Target | Glutathione S-Transferase A3 | | | | | | |
Dihydrofolate Reductase | | Target | Target | Glutathione S-Transferase A3 | | | | | | |
Mu Opioid Receptor | | Target | Target | Beta-Adrenergic Receptor Kinase 2 | | | | | | |
Dpdpe | | Drug | Target | Beta-Adrenergic Receptor Kinase 2 | | | | | | |
ADRBK2 | | Target | Target | Beta-Adrenergic Receptor Kinase 2 | | | | | | |
Cancer | | Disease | Drug | Aflibercept (Eylea)- FDA | | | | | | |
Cancer | | Disease | Drug | Amifostine (Ethyol)- FDA | | | | | | |
Cancer | | Disease | Drug | Aredia (Pamidronate Disodium)- FDA | | | | | | |
Infection | | Disease | Disease | Meningitis Bacterial | | | | | | |
Infection | | Disease | Target | BMP-14 | | | | | | |
Infection | | Disease | Drug | Amifostine (Ethyol)- FDA | | | | | | |
Pain | | Disease | Disease | Meningitis Bacterial | | | | | | |
Diabetes | | Disease | Drug | Amifostine (Ethyol)- FDA | | | | | | |
Collagen | | Target | Target | BMP-14 | | | | | | |
Shock | | Disease | Disease | Meningitis Bacterial | | | | | | |
Fracture | | Disease | Drug | Aredia (Pamidronate Disodium)- FDA | | | | | | |
Fracture | | Disease | Target | BMP-14 | | | | | | |
Asthma | | Disease | Disease | Meningitis Bacterial | | | | | | |
Hemorrhage | | Disease | Disease | Meningitis Bacterial | | | | | | |
Lung Cancer | | Disease | Drug | Amifostine (Ethyol)- FDA | | | | | | |
Lung Cancer | | Disease | Drug | Aflibercept (Eylea)- FDA | | | | | | |